Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphatidylinositol 3-kinase gamma (PI3Kγ) is a lipid kinase that phosphorylates phosphatidylinositol(4,5)-bisphosphate [PI(4,5)P₂] to generate phosphatidylinositol(3,4,5)-trisphosphate [PI(3,4,5)P₃]. It plays a crucial role in immune cell function, particularly in myeloid cells, and is involved in chemotaxis, cytokine release, and inflammatory responses. PI3Kγ is activated downstream of G protein-coupled receptors (GPCRs) and receptor tyrosine kinases. It is considered a drug target for cancer therapy and immune disorders.
Inhibition of PI3Kγ catalytic activity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphatidylinositol 3-kinase gamma catalytic subunit (PI3Kγ).